A diagnostic prediction model was established based on the clinical characteristics of multicenter children with Kawasaki disease in Xinjiang

Read full text
Authors: Muqing Niu, Zhaotang Lin, Fengling Zhang, Yonglin Chen, L. ZHANG, Jinyong Pan, Cailing Chen, Hongbin Yang, L. -C. Mao, Lijuan Chen, Hua Guan, Yong Sun
+2 more Zhou Zhang, Jing Lv
Cited by: 1
References: 14

Abstract

Introduction: Kawasaki disease (KD) is a serious pediatric systemic vasculitis that may cause cardiovascular complications, including coronary artery lesions (CAL). This study aimed to evaluate the predictive value of peripheral blood lymphocyte subsets for intravenous immunoglobulin (IVIG) treatment sensitivity in children with KD in Xinjiang. Methods: This multicenter retrospective study collected clinical and laboratory data from 142 children with KD and 120 controls with infectious fever across several hospitals in Xinjiang from June 2022 to December 2024. Peripheral blood lymphocyte subsets and immunoglobulins were analyzed. Multivariate logistic regression was used to identify risk factors for IVIG non-responsiveness, and ROC curve analyses were performed to evaluate diagnostic efficacy. Results: Significant differences in lymphocyte subsets were observed between KD and control groups, including CD3+, CD4+, CD8+, CD19+, and the CD4+/CD8+ ratio. Multivariate logistic regression identified CD4+ cell count as an independent risk factor for IVIG non-responsiveness. ROC analyses suggested that lymphocyte subsets and immunoglobulins (including CD3+, CD+, CD16+CD56+, IgA, and IgM) have diagnostic potential, with CD8+ and CD+ showing high sensitivity and specificity. Discussion: Peripheral blood lymphocyte subsets, particularly CD4+, may serve as useful biomarkers for predicting IVIG treatment response and distinguishing KD from other febrile illnesses. Further studies with larger sample sizes are warranted to refine predictive models and improve KD management.

Fields of Study & Subjects

Kawasaki Disease and Coronary Complications Vasculitis and related conditions Inflammation biomarkers and pathways

Publication details

Journal / source
Frontiers in Cardiovascular Medicine
Publisher
Frontiers Media SA
Volume
12
Pages
1608572–1608572
Publication date
6 January 2026
Language
EN